India-EU FTA may take effect in 4-5 months, Goyal says

 

BIZ MASALA  |  BUSINESS • MARKETS • PEOPLE • INSIGHT

Minister urges companies to prepare for the trade pact; €310-billion India-Germany trade is an ambition, not a forecast

Union Commerce and Industry Minister Piyush Goyal. (Image supplied by the editor)

The agreement has cleared the negotiation stage, but it is not yet in force. Businesses can begin preparing now, while the signature and domestic approval process continues.

By Biz Masala Desk

India’s free trade agreement with the European Union could take effect in four to five months, Commerce and Industry Minister Piyush Goyal said on October 22, urging companies to begin preparing for the opportunities rather than wait for the pact to become operational.

The agreement is not yet in force. India and the EU announced the conclusion of negotiations on January 27, 2026. The European Commission says it proposed the next steps for signature and conclusion to the Council in September. Council adoption, signature, European Parliament approval, the Council’s conclusion decision and India’s ratification still stand between the negotiated text and implementation.

The agreement’s own entry-into-force clause links the start date to completion of each side’s internal procedures and exchange of written notifications. India’s Commerce Ministry says it would take effect on the first day of the second month after those notifications, unless both sides agree on another date. Goyal’s four-to-five-month estimate is therefore a projection, not a confirmed start date.

A trade pact businesses can prepare for now

At the inauguration of the India Centre of the German Council on Foreign Relations, Goyal asked companies to identify potential partners, exchange product samples and clarify quality requirements and pricing. Those steps matter because lower tariffs alone do not secure orders: exporters still need to meet buyer specifications, document origin, and comply with customs and product rules.

The Department of Commerce’s January factsheet says 70.4% of tariff lines, covering 90.7% of India’s exports to the EU, are set for immediate duty elimination. It highlights labour-intensive categories including textiles, leather and footwear, tea, coffee, spices, sports goods, toys, gems and jewellery, and some marine products. Other tariff reductions are phased or subject to quotas, so firms will need to check the exact product schedule before pricing shipments.

For Indian manufacturers and exporters, practical preparation includes mapping product codes to the final tariff schedule, checking rules of origin and record-keeping needs, reviewing EU product and food-safety standards, and testing landed-cost assumptions with buyers. Firms should also check whether a product’s tariff benefit begins immediately or only after a transition period.

India’s regional diversity is one part of its export base. (Map supplied by the editor)

€310 billion: an ambitious India-Germany target

Goyal also challenged Indian and German businesses to raise bilateral trade to €310 billion from about €31 billion. Moneycontrol reported that India-Germany goods trade was €31.33 billion in 2025, based on German trade data. The minister did not set a deadline for the €310-billion ambition, and the figure should not be confused with an official forecast or a target for India-EU trade as a whole.

He pointed to artificial intelligence, semiconductors, advanced manufacturing, critical minerals, green hydrogen, renewable energy and energy storage as areas for closer cooperation. The scale-up he described would require companies to pair trade with investment, manufacturing partnerships, research links and stronger supply chains.

The FTA can reduce tariff barriers and make market access more predictable, but the agreement cannot by itself create demand or make every Indian supplier export-ready. German and wider European buyers will weigh quality, delivery reliability, regulatory compliance, price and after-sales support alongside tariff savings. The commercial test will be how quickly firms convert the new terms into repeat orders and investment.

European Union countries. (Map supplied by the editor)

The next milestones

Companies can use the waiting period to review the agreement’s published tariff schedules, identify which products qualify, and talk to buyers and logistics partners. The milestones to watch are the Council’s action on signature, formal signing, European Parliament approval, India’s ratification and the exchange of completion notifications. Until those steps are completed, the four-to-five-month timeline remains conditional.

Sources

·       Moneycontrol: Goyal’s timeline, business advice and India-Germany trade ambition — https://www.moneycontrol.com/news/business/piyush-goyal-sees-india-eu-fta-kicking-in-within-4-5-months-eyes-310-billion-india-germany-trade-14057843.html

·       European Commission: status and next steps for the EU-India trade agreement — https://commission.europa.eu/topics/trade/eu-india-trade-agreement_en

·       Department of Commerce: India-EU FTA factsheet and tariff access — https://www.commerce.gov.in/wp-content/uploads/2026/01/Factsheet-on-India-EU-trade-deal-27.1.2026.pdf

·       Press Information Bureau: entry-into-force procedure — https://www.pib.gov.in/PressReleasePage.aspx?PRID=2220413&lang=1&reg=3

·       Consulate General of India, Munich: India-Germany merchandise trade table — https://cgimunich.gov.in/pages/NTIw

Comments

Post a Comment

Popular posts from this blog

THE GREAT INDIAN CINEMA RESET

Image
  BIZ MASALA | BUSINESS. MARKETS. PEOPLE. INSIGHT. From Bollywood's dominance to the pan-India blockbuster: how regional cinema, streaming and changing audience behaviour rewrote the business of Indian films By Murthy ASR | Biz Masala | 17 October 2026 Hero artwork created for this story; conceptual illustration, not a documentary photograph. The opening scene: A business no longer controlled by one city For decades, Mumbai occupied the commanding heights of Indian cinema. Hindi films enjoyed cultural and commercial reach, while Telugu, Tamil, Malayalam and Kannada cinema had powerful home markets but more limited national distribution. S. S. Rajamouli's Baahubali: The Beginning (2015) helped demonstrate that a film rooted in one linguistic industry could travel nationally when storytelling, scale, marketing and distribution worked together. Baahubali 2 and later successes from Telugu and Kannada cinema reinforced the lesson. A decade later, dubbed releases are ...
Read more

SINGARENI COAL PUZZLE : THE CONTRACT QUESTION

Image
  What the CAG found in Singareni’s coal operations—and what remains to be answered By Murthy ASR   |   Biz Masala Investigative Series The audit trail is public. The follow-through is the next question. Singareni Collieries Company Limited (SCCL) is jointly owned by the Governments of Telangana (51%) and India (49%). It is not simply a mining company: its coal feeds power generation and industry, and its operating decisions have consequences for workers, consumers and public finances. A subject-specific compliance audit by the Comptroller and Auditor General of India (CAG), covering overburden removal, coal transportation and stowing-material contracts during 2018–19 to 2022–23, put several contract-design and operational questions on the public record. The report was tabled in the Telangana legislature on 30 March 2026. Its findings are historical and specific to the contracts and periods examined; they do not, by themselves, establish the cause of later pro...
Read more

WHO TESTS THE MEDICINES INDIA MAKES?

Image
  BIZ MASALA SIGNATURE STORY Inside the business of pharmaceutical testing laboratories — the money, the market and the science behind a medicine’s quality By Murthy ASR   |   18 October 2026 Illustrative editorial image: pharmaceutical analytical testing laboratory. A medicine may be manufactured on a modern production line, packed in a clean facility and shipped across the world. But before a batch can be trusted, its quality has to be demonstrated. Behind that assurance is a less visible industry: laboratories that test ingredients, finished formulations, impurities, stability and, where relevant, biological characteristics. For India, this is more than a technical service. The country’s pharmaceutical manufacturers supply domestic patients and regulated markets overseas. Their products must meet specifications, documentation requirements and regulatory expectations that vary by medicine and destination. Testing laboratories help generate the evidence on ...
Read more